AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
EFFECTS OF EDUCATIONAL-MATERIALS CONCERNING OSTEOPOROSIS ON WOMENS KNOWLEDGE, BELIEFS, AND BEHAVIOR
Authors: BLALOCK SJ CURREY SS DEVELLIS RF DEVELLIS BM DOOLEY MA
Citation: Sj. Blalock et al., EFFECTS OF EDUCATIONAL-MATERIALS CONCERNING OSTEOPOROSIS ON WOMENS KNOWLEDGE, BELIEFS, AND BEHAVIOR, Arthritis and rheumatism, 41(9), 1998, pp. 609-609
WOMENS KNOWLEDGE AND BELIEFS CONCERNING ESTROGEN AND OSTEOPOROSIS RISK-REDUCTION
Authors: BLALOCK SJ PATTERSON CC DOOLEY MA DEVELLIS RF ORENSTEIN D
Citation: Sj. Blalock et al., WOMENS KNOWLEDGE AND BELIEFS CONCERNING ESTROGEN AND OSTEOPOROSIS RISK-REDUCTION, Arthritis and rheumatism, 41(9), 1998, pp. 612-612
HORMONAL, ENVIRONMENTAL, AND INFECTIOUS RISK-FACTORS FOR DEVELOPING SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: COOPER GS DOOLEY MA TREADWELL EL STCLAIR EW PARKS CG GILKESON GS
Citation: Gs. Cooper et al., HORMONAL, ENVIRONMENTAL, AND INFECTIOUS RISK-FACTORS FOR DEVELOPING SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 41(10), 1998, pp. 1714-1724
ANCA ANTIGEN-SPECIFICITY IN 192 PATIENTS WITH GLOMERULONEPHRITIS (GN), MICROSCOPIC POLYANGIITIS (MPA), OR WEGENERS GRANULOMATOSIS (WG)
Authors: HOGAN SL NACHMAN PH DOOLEY MA SATTERLY KK JENNETTE JC FALK RJ
Citation: Sl. Hogan et al., ANCA ANTIGEN-SPECIFICITY IN 192 PATIENTS WITH GLOMERULONEPHRITIS (GN), MICROSCOPIC POLYANGIITIS (MPA), OR WEGENERS GRANULOMATOSIS (WG), Journal of the American Society of Nephrology, 8, 1997, pp. 417-417
MYCOPHENOLATE MOFETIL THERAPY IN PATIENTS WITH CYCLOPHOSPHAMIDE-(CYP)RESISTANT OR RELAPSING DIFFUSE PROLIFERATIVE LUPUS NEPHRITIS (SLE-DPGN)
Authors: NACHMAN PH DOOLEY MA HOGAN SL AIELLO JR JENNETTE JC FALK RJ
Citation: Ph. Nachman et al., MYCOPHENOLATE MOFETIL THERAPY IN PATIENTS WITH CYCLOPHOSPHAMIDE-(CYP)RESISTANT OR RELAPSING DIFFUSE PROLIFERATIVE LUPUS NEPHRITIS (SLE-DPGN), Journal of the American Society of Nephrology, 8, 1997, pp. 448-448
REMISSION AND RELAPSE IN ANCA SMALL VESSEL VASCULITIS (SVV) BY ANCA ANTIGEN-SPECIFICITY AND BY DISEASE CATEGORY
Authors: NACHMAN PH HOGAN SL DOOLEY MA SATTERLY KK JENNETTE JC FALK RJ
Citation: Ph. Nachman et al., REMISSION AND RELAPSE IN ANCA SMALL VESSEL VASCULITIS (SVV) BY ANCA ANTIGEN-SPECIFICITY AND BY DISEASE CATEGORY, Journal of the American Society of Nephrology, 8, 1997, pp. 449-449
REMISSION, RELAPSE AND SIDE-EFFECTS IN PATIENTS WITH ANCA SMALL VESSEL VASCULITIS (SVV) TREATED WITH INTRAVENOUS (IV) VERSUS ORAL (PO) CYCLOPHOSPHAMIDE (CYP)
Authors: NACHMAN PH HOGAN SL DOOLEY MA SATTERLY KK JENNETTE JC FALK RJ
Citation: Ph. Nachman et al., REMISSION, RELAPSE AND SIDE-EFFECTS IN PATIENTS WITH ANCA SMALL VESSEL VASCULITIS (SVV) TREATED WITH INTRAVENOUS (IV) VERSUS ORAL (PO) CYCLOPHOSPHAMIDE (CYP), Journal of the American Society of Nephrology, 8, 1997, pp. 450-450
CYCLOPHOSPHAMIDE THERAPY OF SEVERE LUPUS NEPHRITIS - REPLY
Authors: DOOLEY MA HOGAN SL JENNETTE JC FALK RJ
Citation: Ma. Dooley et al., CYCLOPHOSPHAMIDE THERAPY OF SEVERE LUPUS NEPHRITIS - REPLY, American journal of kidney diseases, 30(6), 1997, pp. 876-878
CYCLOPHOSPHAMIDE THERAPY FOR LUPUS NEPHRITIS - POOR RENAL SURVIVAL INBLACK-AMERICANS
Authors: DOOLEY MA HOGAN S JENNETTE C FALK R
Citation: Ma. Dooley et al., CYCLOPHOSPHAMIDE THERAPY FOR LUPUS NEPHRITIS - POOR RENAL SURVIVAL INBLACK-AMERICANS, Kidney international, 51(4), 1997, pp. 1188-1195
MYCOPHENYLATE MOFETIL THERAPY IN RESISTANT OR RELAPSING DIFFUSE PROLIFERATIVE LUPUS NEPHRITIS (SLE-DPGN) FOLLOWING CYCLOPHOSPHAMIDE (CYP) THERAPY
Authors: DOOLEY MA NACHMAN PH SATTERLY KK AIELLO JR JENNETTE JC FALK RJ
Citation: Ma. Dooley et al., MYCOPHENYLATE MOFETIL THERAPY IN RESISTANT OR RELAPSING DIFFUSE PROLIFERATIVE LUPUS NEPHRITIS (SLE-DPGN) FOLLOWING CYCLOPHOSPHAMIDE (CYP) THERAPY, Arthritis and rheumatism, 40(9), 1997, pp. 165-165
VALIDATION OF A SELF-ADMINISTERED SCREENING INSTRUMENT FOR FIBROMYALGIA
Authors: DOOLEY MA GIORGINO KB BLALOCK SJ DEVELLIS RF ESTRADA A RICE JR
Citation: Ma. Dooley et al., VALIDATION OF A SELF-ADMINISTERED SCREENING INSTRUMENT FOR FIBROMYALGIA, Arthritis and rheumatism, 40(9), 1997, pp. 590-590
ANCA ANTIGEN-SPECIFICITY AND RESPONSE TO CYCLOPHOSPHAMIDE THERAPY IN PATIENTS WITH GLOMERULONEPHRITIS ALONE (NCGN), MICROSCOPIC POLYANGITIS(MPA), OR WEGENERS GRANULOMATOSIS (WG)
Authors: DOOLEY MA HOGAN SL NACHMAN PH SATTERLY KK JENNETTE JC FALK RJ
Citation: Ma. Dooley et al., ANCA ANTIGEN-SPECIFICITY AND RESPONSE TO CYCLOPHOSPHAMIDE THERAPY IN PATIENTS WITH GLOMERULONEPHRITIS ALONE (NCGN), MICROSCOPIC POLYANGITIS(MPA), OR WEGENERS GRANULOMATOSIS (WG), Arthritis and rheumatism, 40(9), 1997, pp. 818-818
RECOMMENDATIONS FOR EXOGENOUS ESTROGEN TO PREVENT GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN PREMENOPAUSAL WOMEN WITH OLIGO OR AMENORRHEA - COMMENT ON THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY RECOMMENDATIONS FOR THE PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
Authors: BUYON JP DOOLEY MA MEYER WR PETRI M LICCIARDI F
Citation: Jp. Buyon et al., RECOMMENDATIONS FOR EXOGENOUS ESTROGEN TO PREVENT GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN PREMENOPAUSAL WOMEN WITH OLIGO OR AMENORRHEA - COMMENT ON THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY RECOMMENDATIONS FOR THE PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS, Arthritis and rheumatism, 40(8), 1997, pp. 1548-1549
INTERLEUKIN-2 RECEPTOR LEVELS IN SERA OF PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED WITH SULFASALAZINE, PARENTERAL GOLD, OR PLACEBO
Authors: MERKEL PA DOOLEY MA DAWSON DV PISETSKY DS POLISSON RP
Citation: Pa. Merkel et al., INTERLEUKIN-2 RECEPTOR LEVELS IN SERA OF PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED WITH SULFASALAZINE, PARENTERAL GOLD, OR PLACEBO, Journal of rheumatology, 23(11), 1996, pp. 1856-1861
OSTEOPOROSIS PREVENTION IN PREMENOPAUSAL WOMEN - USING A STAGE MODEL APPROACH TO EXAMINE THE PREDICTORS OF BEHAVIOR
Authors: BLALOCK SJ DEVELLIS RF GIORGINO KB DEVELLIS BM GOLD DT DOOLEY MA ANDERSON JJB SMITH SL
Citation: Sj. Blalock et al., OSTEOPOROSIS PREVENTION IN PREMENOPAUSAL WOMEN - USING A STAGE MODEL APPROACH TO EXAMINE THE PREDICTORS OF BEHAVIOR, Health psychology, 15(2), 1996, pp. 84-93
AUTOANTIBODIES THAT STABILIZE THE MOLECULAR INTERACTION OF KU ANTIGENWITH DNA-DEPENDENT PROTEIN-KINASE CATALYTIC SUBUNIT
Authors: SATOH M AJMANI AK STOJANOV L LANGDON JJ OGASAWARA T WANG J DOOLEY MA RICHARDS HB WINFIELD JB CARTER TH REEVES WH
Citation: M. Satoh et al., AUTOANTIBODIES THAT STABILIZE THE MOLECULAR INTERACTION OF KU ANTIGENWITH DNA-DEPENDENT PROTEIN-KINASE CATALYTIC SUBUNIT, Clinical and experimental immunology, 105(3), 1996, pp. 460-467
ASSESSING THE FEASIBILITY OF A SELF-ADMINISTERED SCREENING INSTRUMENTFOR FIBROMYALGIA
Authors: GIORGINO KB DEVELLIS RF BLALOCK SJ RICE JR DOOLEY MA
Citation: Kb. Giorgino et al., ASSESSING THE FEASIBILITY OF A SELF-ADMINISTERED SCREENING INSTRUMENTFOR FIBROMYALGIA, Arthritis and rheumatism, 39(9), 1996, pp. 1762-1762
RENAL SURVIVAL BY RACE IN DIFFUSE PROLIFERATIVE LUPUS GLOMERULONEPHRITIS (SLE-DPGN) TREATED WITH INTRAVENOUS CYCLOPHOSPHAMIDE (IVCY)
Authors: HOGAN SL DOOLEY MA LOWNEY K JENNETTE JC FALK RJ
Citation: Sl. Hogan et al., RENAL SURVIVAL BY RACE IN DIFFUSE PROLIFERATIVE LUPUS GLOMERULONEPHRITIS (SLE-DPGN) TREATED WITH INTRAVENOUS CYCLOPHOSPHAMIDE (IVCY), Journal of the American Society of Nephrology, 6(3), 1995, pp. 421-421
AUTOANTIBODIES TO TOPOISOMERASE-I IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS WITHOUT FEATURES OF SCLERODERMA
Authors: STOJANOV L SATOH M DOOLEY MA KUWANA M JENNETTE JC REEVES WH
Citation: L. Stojanov et al., AUTOANTIBODIES TO TOPOISOMERASE-I IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS WITHOUT FEATURES OF SCLERODERMA, Lupus, 4(4), 1995, pp. 314-317
DISPOSITION AND COVALENT BINDING OF IBUPROFEN AND ITS ACYL GLUCURONIDE IN THE ELDERLY
Authors: CASTILLO M LAM YWF DOOLEY MA STAHL E SMITH PC
Citation: M. Castillo et al., DISPOSITION AND COVALENT BINDING OF IBUPROFEN AND ITS ACYL GLUCURONIDE IN THE ELDERLY, Clinical pharmacology and therapeutics, 57(6), 1995, pp. 636-644
DISPOSITION AND COVALENT BINDING OF SALICYLIC-ACID AND ITS ACYL GLUCURONIDE IN THE ELDERLY
Authors: LIU JH STAHL E DOOLEY MA LAM YWF SMITH PC
Citation: Jh. Liu et al., DISPOSITION AND COVALENT BINDING OF SALICYLIC-ACID AND ITS ACYL GLUCURONIDE IN THE ELDERLY, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 183-183
OSTEOPOROSIS PREVENTION - USING A STAGE MODEL APPROACH TO EXAMINE THEPREDICTORS OF EXERCISE ACTIVITY AND CALCIUM CONSUMPTION
Authors: BLALOCK SJ DEVELLIS RF GIORGINO KB DEVELLIS BM GOLD DT DOOLEY MA ANDERSON JJB SMITH SL
Citation: Sj. Blalock et al., OSTEOPOROSIS PREVENTION - USING A STAGE MODEL APPROACH TO EXAMINE THEPREDICTORS OF EXERCISE ACTIVITY AND CALCIUM CONSUMPTION, Arthritis and rheumatism, 38(9), 1995, pp. 949-949
RENAL OUTCOMES OF PATIENTS WITH DIFFUSE PROLIFERATIVE LUPUS GLOMERULONEPHRITIS (SLE-DPGN) TREATED WITH INTRAVENOUS CYCLOPHOSPHAMIDE (IVCY)
Authors: DOOLEY MA HOGAN SL LOWNEY K JENNETTE JC FALK RJ
Citation: Ma. Dooley et al., RENAL OUTCOMES OF PATIENTS WITH DIFFUSE PROLIFERATIVE LUPUS GLOMERULONEPHRITIS (SLE-DPGN) TREATED WITH INTRAVENOUS CYCLOPHOSPHAMIDE (IVCY), Arthritis and rheumatism, 38(9), 1995, pp. 1158-1158
INTERLEUKIN-2 RECEPTOR LEVELS IN THE SERA OF RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH SULFASALAZINE, PARENTERAL GOLD, OR PLACEBO
Authors: MERKEL PA DOOLEY MA DAWSON DV PISETSKY DS POLISSON RP
Citation: Pa. Merkel et al., INTERLEUKIN-2 RECEPTOR LEVELS IN THE SERA OF RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH SULFASALAZINE, PARENTERAL GOLD, OR PLACEBO, Arthritis and rheumatism, 38(9), 1995, pp. 1292-1292
INTERLEUKIN-2 RECEPTOR LEVELS IN THE SERA OF RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH METHOTREXATE
Authors: POLISSON RP DOOLEY MA DAWSON DV PISETSKY DS
Citation: Rp. Polisson et al., INTERLEUKIN-2 RECEPTOR LEVELS IN THE SERA OF RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH METHOTREXATE, Arthritis and rheumatism, 37(1), 1994, pp. 50-56
Risultati: 1-25 | 26-27